Beta Bionics, Inc. (BBNX)
10.41
+0.30
(+2.97%)
USD |
NASDAQ |
Mar 13, 16:00
10.40
-0.01
(-0.10%)
After-Hours: 20:00
Beta Bionics EPS Diluted (Quarterly) : -0.3047 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 1.030 |
| Insulet Corp. | 1.441 |
| Tandem Diabetes Care, Inc. | -0.0087 |
| Accuray, Inc. | -0.1138 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.47M |
| Revenue (Quarterly) | 32.12M |
| Total Expenses (Quarterly) | 45.59M |
| Enterprise Value | 236.78M |
| Gross Profit Margin (Quarterly) | 58.98% |
| Profit Margin (Quarterly) | -41.92% |
| Earnings Yield | -16.13% |
| Normalized Earnings Yield | -14.20 |